These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30617435)

  • 1. Use of a design of experiments approach to optimise production of a recombinant antibody fragment in the periplasm of Escherichia coli: selection of signal peptide and optimal growth conditions.
    Kasli IM; Thomas ORT; Overton TW
    AMB Express; 2019 Jan; 9(1):5. PubMed ID: 30617435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a generic β-lactamase screening system for improved signal peptides for periplasmic targeting of recombinant proteins in Escherichia coli.
    Selas Castiñeiras T; Williams SG; Hitchcock A; Cole JA; Smith DC; Overton TW
    Sci Rep; 2018 May; 8(1):6986. PubMed ID: 29725125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
    Sharma SK; Suresh MR; Wuest FR
    Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.
    Kipriyanov SM; Moldenhauer G; Little M
    J Immunol Methods; 1997 Jan; 200(1-2):69-77. PubMed ID: 9005945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procaryotic expression of single-chain variable-fragment (scFv) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli.
    Rippmann JF; Klein M; Hoischen C; Brocks B; Rettig WJ; Gumpert J; Pfizenmaier K; Mattes R; Moosmayer D
    Appl Environ Microbiol; 1998 Dec; 64(12):4862-9. PubMed ID: 9835575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective batch production process of scFv antibody in Escherichia coli.
    Mesgari-Shadi A; Sarrafzadeh MH; Barar J; Omidi Y
    Hum Antibodies; 2017; 26(3):149-157. PubMed ID: 29526846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Periplasmic Expression in Escherichia coli for the Production of Recombinant Proteins Tagged with the Small Metal-Binding Protein SmbP.
    Santos BD; Morones-Ramirez JR; Balderas-Renteria I; Casillas-Vega NG; Galbraith DW; Zarate X
    Mol Biotechnol; 2019 Jun; 61(6):451-460. PubMed ID: 30997666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
    Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
    Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains.
    Lakowitz A; Krull R; Biedendieck R
    Microb Cell Fact; 2017 Jan; 16(1):14. PubMed ID: 28115011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of factors impeding the production of a single-chain antibody fragment in Escherichia coliby comparing in vivo and in vitro expression.
    Oelschlaeger P; Lange S; Schmitt J; Siemann M; Reuss M; Schmid RD
    Appl Microbiol Biotechnol; 2003 Apr; 61(2):123-32. PubMed ID: 12655454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational Targeting of a Recombinant Protein Promotes Its Efficient Secretion into the Escherichia coli Periplasm.
    Ytterberg AJ; Zubarev RA; Baumgarten T
    Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 31003980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform.
    Aghdam MA; Tohidkia MR; Ghamghami E; Ahmadikhah A; Khanmahamadi M; Baradaran B; Mokhtarzadeh A
    Adv Pharm Bull; 2022 May; 12(3):583-592. PubMed ID: 35935041
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing Recombinant Protein Yields in the
    Karyolaimos A; Ampah-Korsah H; Hillenaar T; Mestre Borras A; Dolata KM; Sievers S; Riedel K; Daniels R; de Gier JW
    Front Microbiol; 2019; 10():1511. PubMed ID: 31396164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Recombinant Protein Production in the Escherichia coli Periplasm Alleviates Stress.
    Baumgarten T; Ytterberg AJ; Zubarev RA; de Gier JW
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29654183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification optimization for a recombinant single-chain variable fragment against type 1 insulin-like growth factor receptor (IGF-1R) by using design of experiment (DoE).
    Song YH; Sun XW; Jiang B; Liu JE; Su XH
    Protein Expr Purif; 2015 Dec; 116():98-104. PubMed ID: 26297993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antibody fragment secretion into the Escherichia coli periplasm by co-expression with the peptidyl prolyl isomerase, FkpA, in the cytoplasm.
    Levy R; Ahluwalia K; Bohmann DJ; Giang HM; Schwimmer LJ; Issafras H; Reddy NB; Chan C; Horwitz AH; Takeuchi T
    J Immunol Methods; 2013 Aug; 394(1-2):10-21. PubMed ID: 23624043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of production of a domoic acid-binding scFv antibody fragment in Escherichia coli using molecular chaperones and functional immobilisation on a mesoporous silicate support.
    Hu X; O'Hara L; White S; Magner E; Kane M; Wall JG
    Protein Expr Purif; 2007 Mar; 52(1):194-201. PubMed ID: 17005419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
    Hayhurst A
    Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yields and product comparison between Escherichia coli BL21 and W3110 in industrially relevant conditions: anti-c-Met scFv as a case study.
    Arauzo-Aguilera K; Buscajoni L; Koch K; Thompson G; Robinson C; Berkemeyer M
    Microb Cell Fact; 2023 May; 22(1):104. PubMed ID: 37208750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for high-throughput quantification of periplasmic recombinant proteins.
    Osgerby A; Overton TW
    N Biotechnol; 2023 Nov; 77():149-160. PubMed ID: 37708933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.